Meet the team at Booth #409 Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with…
Browsing: HealthCare
Legend Capital recently announced that it made its 100th IPO following the listing of its AI medical portfolio company Lunit…
Colorectal cancer (CRC) has become one of the main cancers threatening the health of human beings. In the United States…
Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled “Evolution…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
aCommerce Group, the largest end-to-end e-commerce enabler in Southeast Asia, has partnered with Johnson & Johnson Philippines, part of the…
This year, CT Event Asia is all set to bring you the Asean Healthcare Transformation Summit 2022, themed “Leveraging Human…
As pharmaceutical reformation is underway, the importance of the innovative strength of biotech companies has become increasingly prominent, the entire…
Pursuing Progress in Revenue, Increased by 14.1% Ensuring Stability and Accommodating the Needs for Pandemic Control The board of directors…
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand…
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter…
Application Scenario Solutions Open Up Broad New Prospects in Assisted Reproduction Suzhou Basecare Medical Corporation Limited (Basecare Medicalor the Company,…
Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards – Biotech Company of the Year Private…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has…
— NVK002 completed patient recruitment for both concurrent Phase III clinical trials significantly ahead of schedule — First commercialized product,…
Avantor Foundation, Avantor’s philanthropic arm, committed financial resources to healthcare charitable organizations, HealthServe and SATA CommHealth, as part of the…
Positive Phase 2 data, published in Clinical Ophthalmology, highlights the potential of licaminlimab to become a novel treatment in DED…
Benefitted from Years of Huge Investment in R&D Sales of New Products Accounts for 43.5% of Revenue Sino Biopharmaceutical Limited…
With the Launch of Four Ischemic Products, the Product Portfolio for the Ischemic Product Line Has Been Preliminarily Established Established…
IVD Medical Holding Limited (IVD Medical or the Group), a leading distributor of In Vitro Diagnostic (IVD(1) products in the…